Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors-Reference-Cited by-同舟云学术

Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors

Published:2023-04 Issue: Volume:171 Page:151-158
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Osann Kathryn,Wenzel Lari,McKinney Chelsea,Wagner Lynne,Cella David,Fulci Giulia,Scroggins Mary J.,Lankes Heather A.,Wang Victoria,Nephew Kenneth P.,Maxwell George L.,Mok Samuel C.,Conrads Thomas P.,Miller Austin,Birrer Michael

Funder

Chao Family Comprehensive Cancer Center

National Institutes of Health

U.S. Department of Defense

National Cancer Institute

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference44 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. The prognostic significance of patient-reported outcomes in cancer clinical trials;Gotay;J. Clin. Oncol.,2008

3. Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: an ancillary data analysis of the NRG oncology/gynecologic oncology group (GOG-0218) study;Phippen;Gynecol. Oncol.,2017

4. The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a gynecologic oncology group study;von Gruenigen;Gynecol. Oncol.,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermic intraperitoneal chemotherapy (HIPEC) vs. postoperative intraperitoneal (IP) chemotherapy – Impact on health-related quality of life in primary ovarian cancer patients after cytoreductive surgery;Surgical Oncology Insight;2024-09

2. Identifying Factors Contributing to Delayed Diagnosis of Ovarian Cancer: A Comprehensive Analysis;International Journal of Women's Health;2024-09

3. Symptom burden, palliative care knowledge, and palliative care needs in advanced gynecological cancer patients in Korea;Supportive Care in Cancer;2024-08-10

4. Specific antitumor activity of anti-CA125 CAR-T lymphocytes against CA125-positive and CA125-negative cells;Sechenov Medical Journal;2024-07-31

5. Combined aqupla, paclitaxel liposome, and docetaxel treatment: survival and biomarker outcomes in recurrent ovarian cancer patients;Frontiers in Oncology;2024-06-17